Moyo, Victor
Merrimack Pharmaceuticals (United States)
3 papers on CoChatORCID 0000-0001-8470-5347
Most cited papers
- Verified
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Wang-Gillam, A., Li, C.-P., Bodoky, G., Dean, A., Shan, Y.-S., Jameson, G., Macarulla, T., Lee, K.-H., Cunningham, D., Blanc, J. F., et al. (2016) · The Lancet
Pancreatic and Hepatic Oncology ResearchCancer Treatment and Pharmacology
Cited by 1,222
- Verified
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene☆
Gordeuk, V. R., Caleffi, A., Corradini, E., Ferrara, F., Jones, R. A., Castro, O., Onyekwere, O., Kittles, R., Pignatti, E., Montosi, G., et al. (2003) · Blood Cells, Molecules, and Diseases
Iron Metabolism and DisordersNeurological diseases and metabolism
Cited by 198
- Verified
Association of Pulmonary Tuberculosis with Increased Dietary Iron
Gangaidzo, I. T., Moyo, V. M., Mvundura, E., Aggrey, G., Murphree, N. L., Khumalo, H., Saungweme, T., Kasvosve, I., Gomo, Z. A. R., Rouault, T., et al. (2001) · The Journal of Infectious Diseases
Tuberculosis Research and EpidemiologyIron Metabolism and Disorders
Cited by 191
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free